// App-Quantinova.ai

e11566 : Taxane associated with trastuzumab-induced early ventricular impairment: Correlation with biologic markers of chronic inflammation and oxidative stress.

Researchers

Presenter

  • Clelia Madeddu

Principal Investigators

  • Mariele Dessi'

  • Martino Deidda

  • Giovanni Mantovani

  • Giuseppe Mercuro

  • Christian CadedDuAlessandra Piras

  • Giorgia Antoni

Medical Centers

  • Department of Medical Sciences Mario Aresu, Medical Oncology, University of Cagliari, Cagliari, Italy

  • Department of Medical Sciences Mario Aresu, Service of Medical Oncology, University of Cagliari, Cagliari, ItalyDepartment of Cardiovascular and Neurological Sciences, University of Cagliari, Cagliari, ItalyDepartment of Medical Sciences Mario Aresu, Medical Oncology, University of Cagliari, Cagliari, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Cardiotoxicity

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Interleukin 6

Drug/Treatment

  • glutathione

  • Trastuzumab

  • taxane

Outcome

  • Positive

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved